Literature DB >> 24055020

Selective modulation of lymphoproliferation and cytokine production via intracellular signaling targets by α1- and α2-adrenoceptors and estrogen in splenocytes.

Hannah P Priyanka1, Srinivasan ThyagaRajan.   

Abstract

UNLABELLED: The mechanistic implications of the presence of sympathetic noradrenergic innervation in lymphoid organs in synaptic association with lymphocytes open to the influence of hormonal fluctuations throughout reproductive age in females has not been investigated yet.
OBJECTIVES: The aim of the present study is to investigate the role of alpha-adrenoceptors (α-ARs) and estrogen in modulating immune responses in the spleen through intracellular signaling targets such as ERK 1/2, CREB, Akt, NF-κB.
METHODS: Splenocytes from young Sprague-Dawley rats were incubated with α1- and α2- AR specific agonists, phenylephrine and clonidine, without and with 17b-estradiol or specific antagonists prazosin and idazoxan to examine their effects on proliferation, cytokine production, nitric oxide production, and intracellular signaling molecules.
RESULTS: α1-AR stimulation inhibited lymphocyte proliferation and IFN-g production and enhanced IL-2, p-ERK and p-CREB expression. Co-stimulation using estrogen enhanced cytokine production and suppressed p-Akt expression. α1-AR blockade reversed agonist-induced IL-2 production alone. α2-AR stimulation inhibited lymphocyte proliferation, p-ERK and p-CREB expression, and increased p-NF-kB and p-Akt expression. Co-stimulation with estrogen increased IL-2 and suppressed p-CREB expression. α2-AR Idazoxan prevented IL-2 production in the absence and presence of estrogen, and reversed clonidine-induced increase in NO production and p-ERK and p-Akt expression in the presence of estrogen.
CONCLUSIONS: These results suggest that the cell-mediated immune responses are selectively modulated depending upon the subtypes of α-AR and further, these effects are differentially regulated in the presence of estrogen mediated through selective alteration in the intracellular signaling pathways involving ERK, CREB, Akt, and NF-κB.
© 2013.

Entities:  

Keywords:  Clonidine; Idazoxan; NF-κB; Nitric oxide; Phenylephrine; Prazosin

Mesh:

Substances:

Year:  2013        PMID: 24055020     DOI: 10.1016/j.intimp.2013.08.020

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions.

Authors:  Serena Boccella; Monica Iannotta; Claudia Cristiano; Fabio Arturo Iannotti; Fabio Del Bello; Francesca Guida; Carmela Belardo; Rosmara Infantino; Flavia Ricciardi; Mario Giannella; Antonio Calignano; Vincenzo Di Marzo; Sabatino Maione; Livio Luongo
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

Review 2.  Neuroimmunomodulation by estrogen in health and disease.

Authors:  Hannah P Priyanka; Rahul S Nair
Journal:  AIMS Neurosci       Date:  2020-10-30

3.  17β-Estradiol Concentration and Direct β2-Adrenoceptor Inhibition Determine Estrogen-Mediated Reversal of Adrenergic Immunosuppression.

Authors:  Hannah P Priyanka; A Thiyagaraj; G Krithika; R S Nair; W Hopper; S ThyagaRajan
Journal:  Ann Neurosci       Date:  2022-03-03

4.  Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic.

Authors:  Sharon W Way; Joseph R Podojil; Benjamin L Clayton; Anita Zaremba; Tassie L Collins; Rejani B Kunjamma; Andrew P Robinson; Pedro Brugarolas; Robert H Miller; Stephen D Miller; Brian Popko
Journal:  Nat Commun       Date:  2015-03-13       Impact factor: 14.919

Review 5.  Which idea is better with regard to immune response? Opioid anesthesia or opioid free anesthesia.

Authors:  Barbara Lisowska; Jakub Jakubiak; Katarzyna Siewruk; Maria Sady; Dariusz Kosson
Journal:  J Inflamm Res       Date:  2020-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.